References Cited

Lung Cancer

American Cancer Society. (2025). Key statistics for lung cancer. https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.html

Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K. E., Doubeni, C. A., Epling, J. W., Kubik, M., Landefeld, C. S., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C.-W., & Wong, J. B. (2021). Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. JAMA, 325(10), 962–970. https://doi.org/10.1001/jama.2021.1117

National Cancer Institute. (2024). Lung cancer screening (PDQ®)–Health professional version. https://www.cancer.gov/types/lung/hp/lung-screening-pdq

Richards, T. B., Doria-Rose, V. P., Soman, A., Klabunde, C. N., Caraballo, R. S., Gray, S. C., & White, M. C. (2020). Lung cancer screening inconsistent with U.S. Preventive Services Task Force recommendations. American Journal of Preventive Medicine, 58(1), 66–73. https://doi.org/10.1016/j.amepre.2019.08.030

Liver Cancer (Hepatocellular Carcinoma)

American Association for the Study of Liver Diseases. (2018). Hepatocellular carcinoma: Diagnosis, staging, and management. Hepatology, 68(2), 723–750. https://doi.org/10.1002/hep.29913

National Cancer Institute. (2024). Liver (hepatocellular) cancer screening (PDQ®)–Health professional version. https://www.cancer.gov/types/liver/hp/liver-screening-pdq

Singal, A. G., Lampertico, P., & Nahon, P. (2020). Epidemiology and surveillance for hepatocellular carcinoma: New trends. Journal of Hepatology, 72(2), 250–261. https://doi.org/10.1016/j.jhep.2019.08.025

Wolf, E., Rich, N. E., Marrero, J. A., Parikh, N. D., & Singal, A. G. (2021). Use of hepatocellular carcinoma surveillance in patients with cirrhosis: A systematic review and meta-analysis. Hepatology, 73(2), 713–725. https://doi.org/10.1002/hep.31214

Ovarian Cancer

National Cancer Institute. (2024). Ovarian cancer—Patient version. https://www.cancer.gov/types/ovarian

U.S. Preventive Services Task Force. (2018). Screening for ovarian cancer: U.S. Preventive Services Task Force recommendation statement. JAMA, 319(6), 588–594. https://doi.org/10.1001/jama.2017.21926

U.S. Preventive Services Task Force. (2018). Final recommendation statement: Ovarian cancer—Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening

American Cancer Society. (2025). Key statistics for ovarian cancer. https://www.cancer.org/cancer/types/ovarian-cancer/about/key-statistics.html

Reid, B. M., Permuth, J. B., & Sellers, T. A. (2017). Epidemiology of ovarian cancer: A review. Cancer Biology & Medicine, 14(1), 9–32. https://doi.org/10.20892/j.issn.2095-3941.2016.0084